BENGALURU - Glenmark Pharmaceuticals Ltd said on Tuesday it will begin a new clinical trial in India to test a combination of two anti-viral drugs - favipiravir and..
Technical Trading Idea
* Glenmark started moving in a consolidation phase after a sharp rally and thus, resulted into formation of a Bullish Pennant pattern on daily c..
Glenmark Pharmaceuticals said on Tuesday that it has initiated phase - three clinical trials on antiviral Favipiravir for COVID-19 patients in India.
Glenmark Pharmaceuticals on Monday said it has launched a triple therapy inhaler in the country for patients with chronic obstructive pulmonary disease (COPD). The compan..
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel https://t.me/Investment..
* Samvat 2074 was like very volatile period for the Market due to both local and global events like Rate hikes, trade war between US and China, FII..
Accelya Solutions In Q4 net profit up 32.35% at Rs 24.71 cr
US dollar rises after Fed policy meeting
Rupee rises by 12 paise to Rs 69.05 against dollar
Headwinds recede for Tata Motors, but it is not out of the woods just yet
Infosys signs agreement with U.S. IRS; sees lower tax rate
Daily Market Commentary 28 May 2020 by Mr. Siddhartha Khemka, Motilal Oswal
Market Viewpoint 28/05/2020 By Mr Sameet Chavan,Chief Analyst, Angel Broking
Stock Market Prediction 29 May 2020
May series ends with a bang by Mr. Sameet Chavan, Angel Broking
© Copyright 2017 - investmentguruindia | All Rights Reserved. | Crafted By - Digi Interface